1. Home
  2. LOCL vs NOTV Comparison

LOCL vs NOTV Comparison

Compare LOCL & NOTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Local Bounti Corporation

LOCL

Local Bounti Corporation

HOLD

Current Price

$2.57

Market Cap

54.0M

ML Signal

HOLD

Logo Inotiv Inc.

NOTV

Inotiv Inc.

HOLD

Current Price

$0.76

Market Cap

29.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LOCL
NOTV
Founded
2021
1974
Country
United States
United States
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
54.0M
29.9M
IPO Year
N/A
1997

Fundamental Metrics

Financial Performance
Metric
LOCL
NOTV
Price
$2.57
$0.76
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$3.00
AVG Volume (30 Days)
17.7K
1.6M
Earning Date
11-12-2025
12-03-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$45,978,000.00
$513,024,000.00
Revenue This Year
$36.93
$6.26
Revenue Next Year
$82.62
$45.49
P/E Ratio
N/A
N/A
Revenue Growth
31.61
4.54
52 Week Low
$1.18
$0.66
52 Week High
$5.75
$6.48

Technical Indicators

Market Signals
Indicator
LOCL
NOTV
Relative Strength Index (RSI) 50.97 35.16
Support Level $2.48 $0.79
Resistance Level $2.80 $0.86
Average True Range (ATR) 0.21 0.07
MACD 0.03 0.01
Stochastic Oscillator 58.47 3.93

Price Performance

Historical Comparison
LOCL
NOTV

About LOCL Local Bounti Corporation

Local Bounti Corp is a controlled environment agriculture company. Its business model is based on building local facilities, operated by local teams, to deliver fresh and quality produce to local communities while maintaining a limited carbon footprint. Using proprietary technology to grow leafy greens and herbs in smart greenhouses with a cultivation process that uses less water and land than conventional agriculture, free from herbicides or pesticides, it delivers products that have a longer shelf life, and are good in taste.

About NOTV Inotiv Inc.

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.

Share on Social Networks: